Drugs that contain Calcipotriene

1. Sorilux patents expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US8629128 MAYNE PHARMA Vitamin formulation
May, 2026

(2 years from now)

US8263580 MAYNE PHARMA Vitamin formulation
May, 2028

(4 years from now)

Drug Exclusivity Drug Exclusivity Expiration
New Patient Population (NPP) Nov 5, 2022

Market Authorisation Date: 06 October, 2010

Treatment: Use of a calcipotriene containing foam for the treatment of psoriasis; Use of calcipotriene foam for the topical treatment of plaque psoriasis in patients aged 18 years and older; Use of calcipotriene...


More Information on Dosage

SORILUX family patents

Family Patents